CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product

CannaPharmaRx, Inc. (OTC PINK:CPMD), a company specializing in efficient cannabis production, has announced receipt of three purchase orders from Cantek Holdings totaling 600KG of cannabis. These orders are part of a prior supply agreement and signify market satisfaction with CannaPharmaRx's quality methodologies. Future orders are expected approximately once or twice a month. Cantek is recognized as a leader in Israel’s medical cannabis sector.

The Cremona facility of CannaPharmaRx continues to produce over 1000KG of high-quality cannabis quarterly. The company has completed fifteen production cycles, regularly shipping inventory every two to three weeks. A recent 150KG shipment swiftly cleared Israeli customs and sold out rapidly. An additional 150KG is en route, with a 300KG order pending an export license.

CannaPharmaRx aims to expand its partnerships in Europe and Latin America by Q4 2024. The company is leveraging its current successes to grow its international presence. Positioned in some of the largest cannabis markets globally, CannaPharmaRx remains focused on strategic growth.